Skip to main content

Kimberly-Clark Corp

Exchange: NASDAQSector: Consumer DefensiveIndustry: Household & Personal Products

Kimberly-Clark Corporation (Kimberly Clark) is a global company focused on the world in essentials for a better life through product innovation and building its personal care, consumer tissue, K C professional and health care brands. The Company is principally engaged in the manufacturing and marketing of a wide ranges of products made from natural or synthetic fibers using advanced technologies in fibers, nonwovens and absorbency. Its operating segments include Personal Care , Consumer Tissue K C Professional and HealthCare. The Company operates and markets its products globally in Asia, Latin America, Eastern Europe, the Middle East and Africa, with a particular emphasis in China, Russia and Latin America. In April 2013, it announced the acquisition of the anesthesia business of Life-Tech, Inc.

Did you know?

Profit margin stands at 12.8%.

Current Price

$97.67

-0.77%

GoodMoat Value

$93.54

4.2% overvalued
Profile
Valuation (TTM)
Market Cap$32.42B
P/E15.30
EV$39.48B
P/B21.58
Shares Out331.92M
P/Sales1.96
Revenue$16.56B
EV/EBITDA10.30

Kimberly-Clark Corp (KMB) Valuation

GoodMoat Analysis

Based on data as of March 26, 2026

Kimberly-Clark appears fairly valued to slightly overvalued from a strict value perspective. The current price is modestly above the GoodMoat Target, offering no margin of safety, and its P/E is at a premium to its sector despite weak growth.

Read full analysis
The current price of $99.36 is approximately 6% above the GoodMoat Target of $93.54. According to the framework's DCF-based Margin of Safety (MoS) bands, this results in a negative MoS, placing the valuation in the 'Unfavourable' category (<10%). The stock does not offer a discount to its estimated intrinsic value. The forward P/E of 16.3x is slightly above the sector average for consumer defensive stocks, which typically trade in the low-to-mid teens. This premium is notable given the company's negative revenue growth of -0.6% YoY, suggesting the market is paying for stability and a high dividend rather than growth. Historically, KMB's P/E has often ranged higher, but the current multiple relative to its near-zero growth profile appears full. The 5.0% Free Cash Flow Yield and 5.03% Dividend Yield provide some support, but the high Debt/Equity ratio of 4.77 is a concern that may pressure valuation. Integrating this with the business quality assessment, the stock appears expensive relative to its current operational performance, trading on brand strength and yield rather than a clear margin of safety. A value investor would likely find the valuation unattractive without a more significant price decline. Analysis based on data as of 2024-05-15.

KMB Fair Value Estimate

$93.544.2% overvalued

Blended fair value estimate based on DCF, Graham Number, and earnings-based models.

KMB Valuation Metrics

FCF$1.64B
FCF Growth Rate-1.26%
EPS Growth (CAGR)-1.08%
WACC10.00%

KMB Valuation & Fair Value Analysis

Kimberly-Clark Corp (KMB) valuation analysis using multiple fair value methodologies. GoodMoat calculates a blended fair value target using discounted cash flow (DCF) analysis, the Graham Number, and earnings-based valuation models.

The GoodMoat Fair Value target for Kimberly-Clark Corp is $93.54. The current stock price is $97.67, suggesting the stock is 4.4% overvalued.

The price-to-earnings (P/E) ratio is 15.30. Price-to-book ratio is 21.58. Price-to-sales ratio is 1.96. Enterprise value to EBITDA is 10.30. PEG ratio is 0.90.

GoodMoat's valuation models include the Graham Number (based on EPS and book value), an earnings-based model (discounted future EPS), and a PEG-adjusted valuation. The three models are averaged to produce a blended fair value estimate. Use these tools alongside the DCF calculator and reverse DCF to form a comprehensive view of Kimberly-Clark Corp's intrinsic value.